Artificial Intelligence in diabetes management is an automotion system which employs a computer system that gathers data, understands, reasons, and learns how the information effects outcomes over time.That the system ingests massive amounts of information—both structured and unstructured data—such as databases that have categorical variables, health records, and the scientific lexicon in research papers all of which is ingested and processed to make connections and then draw conclusions through a process of learning over time to increase in accuracy.
Highlights
The global Artificial Intelligence in Diabetes Management market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Artificial Intelligence in Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Artificial Intelligence in Diabetes Management is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Artificial Intelligence in Diabetes Management in Glucose Monitoring Devices is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Artificial Intelligence in Diabetes Management include Apple, Diabnext, Glooko, Google, IBM, Tidepool and Vodafone, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Artificial Intelligence in Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Artificial Intelligence in Diabetes Management.
The Artificial Intelligence in Diabetes Management market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Artificial Intelligence in Diabetes Management market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Artificial Intelligence in Diabetes Management companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Apple
Diabnext
Glooko
Google
IBM
Tidepool
Vodafone
Segment by Type
Case-based Reasoning
Intelligent Data Analysis
Segment by Application
Glucose Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Artificial Intelligence in Diabetes Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Artificial Intelligence in Diabetes Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Case-based Reasoning
1.2.3 Intelligent Data Analysis
1.3 Market by Application
1.3.1 Global Artificial Intelligence in Diabetes Management Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Glucose Monitoring Devices
1.3.3 Diagnostic Devices
1.3.4 Insulin Delivery Devices
1.3.5 Other Devices
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Artificial Intelligence in Diabetes Management Market Perspective (2018-2029)
2.2 Artificial Intelligence in Diabetes Management Growth Trends by Region
2.2.1 Global Artificial Intelligence in Diabetes Management Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Artificial Intelligence in Diabetes Management Historic Market Size by Region (2018-2023)
2.2.3 Artificial Intelligence in Diabetes Management Forecasted Market Size by Region (2024-2029)
2.3 Artificial Intelligence in Diabetes Management Market Dynamics
2.3.1 Artificial Intelligence in Diabetes Management Industry Trends
2.3.2 Artificial Intelligence in Diabetes Management Market Drivers
2.3.3 Artificial Intelligence in Diabetes Management Market Challenges
2.3.4 Artificial Intelligence in Diabetes Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Artificial Intelligence in Diabetes Management Players by Revenue
3.1.1 Global Top Artificial Intelligence in Diabetes Management Players by Revenue (2018-2023)
3.1.2 Global Artificial Intelligence in Diabetes Management Revenue Market Share by Players (2018-2023)
3.2 Global Artificial Intelligence in Diabetes Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Artificial Intelligence in Diabetes Management Revenue
3.4 Global Artificial Intelligence in Diabetes Management Market Concentration Ratio
3.4.1 Global Artificial Intelligence in Diabetes Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence in Diabetes Management Revenue in 2022
3.5 Artificial Intelligence in Diabetes Management Key Players Head office and Area Served
3.6 Key Players Artificial Intelligence in Diabetes Management Product Solution and Service
3.7 Date of Enter into Artificial Intelligence in Diabetes Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Artificial Intelligence in Diabetes Management Breakdown Data by Type
4.1 Global Artificial Intelligence in Diabetes Management Historic Market Size by Type (2018-2023)
4.2 Global Artificial Intelligence in Diabetes Management Forecasted Market Size by Type (2024-2029)
5 Artificial Intelligence in Diabetes Management Breakdown Data by Application
5.1 Global Artificial Intelligence in Diabetes Management Historic Market Size by Application (2018-2023)
5.2 Global Artificial Intelligence in Diabetes Management Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Artificial Intelligence in Diabetes Management Market Size (2018-2029)
6.2 North America Artificial Intelligence in Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
6.4 North America Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Artificial Intelligence in Diabetes Management Market Size (2018-2029)
7.2 Europe Artificial Intelligence in Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
7.4 Europe Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Artificial Intelligence in Diabetes Management Market Size (2018-2029)
8.2 Asia-Pacific Artificial Intelligence in Diabetes Management Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Artificial Intelligence in Diabetes Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Artificial Intelligence in Diabetes Management Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Artificial Intelligence in Diabetes Management Market Size (2018-2029)
9.2 Latin America Artificial Intelligence in Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
9.4 Latin America Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size (2018-2029)
10.2 Middle East & Africa Artificial Intelligence in Diabetes Management Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Artificial Intelligence in Diabetes Management Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Apple
11.1.1 Apple Company Detail
11.1.2 Apple Business Overview
11.1.3 Apple Artificial Intelligence in Diabetes Management Introduction
11.1.4 Apple Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.1.5 Apple Recent Development
11.2 Diabnext
11.2.1 Diabnext Company Detail
11.2.2 Diabnext Business Overview
11.2.3 Diabnext Artificial Intelligence in Diabetes Management Introduction
11.2.4 Diabnext Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.2.5 Diabnext Recent Development
11.3 Glooko
11.3.1 Glooko Company Detail
11.3.2 Glooko Business Overview
11.3.3 Glooko Artificial Intelligence in Diabetes Management Introduction
11.3.4 Glooko Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.3.5 Glooko Recent Development
11.4 Google
11.4.1 Google Company Detail
11.4.2 Google Business Overview
11.4.3 Google Artificial Intelligence in Diabetes Management Introduction
11.4.4 Google Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.4.5 Google Recent Development
11.5 IBM
11.5.1 IBM Company Detail
11.5.2 IBM Business Overview
11.5.3 IBM Artificial Intelligence in Diabetes Management Introduction
11.5.4 IBM Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.5.5 IBM Recent Development
11.6 Tidepool
11.6.1 Tidepool Company Detail
11.6.2 Tidepool Business Overview
11.6.3 Tidepool Artificial Intelligence in Diabetes Management Introduction
11.6.4 Tidepool Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.6.5 Tidepool Recent Development
11.7 Vodafone
11.7.1 Vodafone Company Detail
11.7.2 Vodafone Business Overview
11.7.3 Vodafone Artificial Intelligence in Diabetes Management Introduction
11.7.4 Vodafone Revenue in Artificial Intelligence in Diabetes Management Business (2018-2023)
11.7.5 Vodafone Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Apple
Diabnext
Glooko
Google
IBM
Tidepool
Vodafone
*If Applicable.